Nutritional status and drug resistance in EGFR-mutant NSCLC: a retrospective cohort study on almonertinib efficacy.
This retrospective study analyzed 56 advanced NSCLC patients with EGFR mutations treated with Almonertinib, stratified b...
This retrospective study analyzed 56 advanced NSCLC patients with EGFR mutations treated with Almonertinib, stratified b...
The publication presents a phase II clinical trial evaluating the efficacy and safety of a novel targeted therapy in pat...
This retrospective study evaluated the impact of renin-angiotensin-aldosterone system inhibitors (RAASi) on outcomes in...
The publication presents a clinical study evaluating the efficacy and safety of a novel therapeutic agent in treating ad...
The publication presents results from a clinical study evaluating the efficacy and safety of a novel targeted therapy in...
This publication reviews the evolving management of stage I to III non-small cell lung cancer (NSCLC), emphasizing advan...